MCH ADVISORY RESEARCHMain site ↗
Sector

Information Technology

122 companies under coverage across 12 industries.

Industries

Browse by industry


Coverage

Information Technology companies


Equity Research

Amphenol Corporation (APH)

BUY. 12-month probability-weighted target $160 (+95% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

APHEquity ResearchMonte Carlo
4 September 2026Rating: BUY · +71.8%
Equity Research

TTM Technologies Inc (TTMI)

BUY. 12-month probability-weighted target $237 (+84% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

TTMIEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +50.4%
Equity Research

Cirrus Logic Inc (CRUS)

BUY. 12-month probability-weighted target $134 (+21% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

CRUSEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +28.8%
Equity Research

Applovin Corp (APP)

BUY. 12-month probability-weighted target $482 (+54% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

APPEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +25.0%
Equity Research

Arrow Electronics Inc (ARW)

HOLD. 12-month probability-weighted target $245 (+13% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

ARWEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +23.5%
Equity Research

Fair Isaac Corporation (FICO)

BUY. 12-month probability-weighted target $1155 (+24% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

FICOEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +22.4%
Equity Research

Ciena Corp (CIEN)

BUY. 12-month probability-weighted target $479 (+27% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

CIENEquity ResearchMonte Carlo
30 August 2026Rating: BUY · +21.2%
Equity Research

Fabrinet (FN)

BUY. 12-month probability-weighted target $501 (+20% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

FNEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +19.2%
Equity Research

IPG Photonics Corporation (IPGP)

BUY. 12-month probability-weighted target $97 (+22% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

IPGPEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +17.2%
Equity Research

Cadence Design Systems Inc (CDNS)

BUY. 12-month probability-weighted target $379 (+33% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CDNSEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +13.0%
Equity Research

NXP Semiconductors NV (NXPI)

BUY. 12-month probability-weighted target $267 (+19% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

NXPIEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +12.1%
Equity Research

ON Semiconductor Corporation (ON)

BUY. 12-month probability-weighted target $88 (+24% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

ONEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +8.4%
Equity Research

CommVault Systems Inc (CVLT)

HOLD. 12-month probability-weighted target $147 (+11% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

CVLTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +8.3%
Equity Research

Vontier Corp (VNT)

BUY. 12-month probability-weighted target $40 (+23% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

VNTEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +8.1%
Equity Research

Synopsys Inc (SNPS)

HOLD. 12-month probability-weighted target $451 (+15% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SNPSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +7.4%
Equity Research

Flex Ltd (FLEX)

BUY. 12-month probability-weighted target $145 (+27% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

FLEXEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +7.0%
Equity Research

Rambus Inc (RMBS)

BUY. 12-month probability-weighted target $100 (+15% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

RMBSEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +6.6%
Equity Research

Synaptics Incorporated (SYNA)

BUY. 12-month probability-weighted target $112 (+18% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

SYNAEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +6.6%
Equity Research

Western Digital Corporation (WDC)

BUY. 12-month probability-weighted target $533 (+18% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

WDCEquity ResearchMonte Carlo
7 August 2026Rating: BUY · +5.5%
Equity Research

Applied Materials Inc (AMAT)

BUY. 12-month probability-weighted target $624 (+32% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

AMATEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +5.3%
Equity Research

Amkor Technology Inc (AMKR)

BUY. 12-month probability-weighted target $62 (+23% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AMKREquity ResearchMonte Carlo
9 September 2026Rating: BUY · +4.8%
Equity Research

Microchip Technology Inc (MCHP)

BUY. 12-month probability-weighted target $84 (+15% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

MCHPEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +3.6%
Equity Research

KLA Corporation (KLAC)

BUY. 12-month probability-weighted target $249 (+32% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

KLACEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +3.2%
Equity Research

Universal Display (OLED)

HOLD. 12-month probability-weighted target $81 (-1% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

OLEDEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +2.1%
Equity Research

Coherent Inc (COHR)

BUY. 12-month probability-weighted target $378 (+25% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

COHREquity ResearchMonte Carlo
9 September 2026Rating: BUY · +2.0%
Equity Research

Qualcomm Incorporated (QCOM)

HOLD. 12-month probability-weighted target $177 (+2% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

QCOMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · +1.7%
Equity Research

Allegro Microsystems Inc (ALGM)

BUY. 12-month probability-weighted target $47 (+28% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

ALGMEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +1.6%
Equity Research

Qnity Electronics, Inc (Q)

BUY. 12-month probability-weighted target $153 (+24% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

QEquity ResearchMonte Carlo
9 September 2026Rating: BUY · +0.8%
Equity Research

Godaddy Inc (GDDY)

SELL. 12-month probability-weighted target $85 (-9% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

GDDYEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -0.7%
Equity Research

Pegasystems Inc (PEGA)

SELL. 12-month probability-weighted target $32 (-12% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

PEGAEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -1.5%
Equity Research

F5 Networks Inc (FFIV)

HOLD. 12-month probability-weighted target $368 (-6% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

FFIVEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -1.5%
Equity Research

Texas Instruments Incorporated (TXN)

HOLD. 12-month probability-weighted target $280 (+8% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

TXNEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -1.5%
Equity Research

Autodesk Inc (ADSK)

SELL. 12-month probability-weighted target $195 (-8% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADSKEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -1.9%
Equity Research

Analog Devices Inc (ADI)

HOLD. 12-month probability-weighted target $380 (+5% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

ADIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.5%
Equity Research

First Solar Inc. (FSLR)

HOLD. 12-month probability-weighted target $226 (+6% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

FSLREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -2.8%
Equity Research

Cisco Systems Inc (CSCO)

HOLD. 12-month probability-weighted target $114 (+5% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CSCOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -3.7%
Equity Research

International Business Machines (IBM)

HOLD. 12-month probability-weighted target $260 (+12% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

IBMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -3.9%
Equity Research

Bentley Systems Inc (BSY)

HOLD. 12-month probability-weighted target $33 (+0% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

BSYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -4.0%
Equity Research

Dolby Laboratories (DLB)

SELL. 12-month probability-weighted target $52 (-17% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

DLBEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -4.3%
Equity Research

Lam Research Corp (LRCX)

HOLD. 12-month probability-weighted target $331 (+3% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

LRCXEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.3%
Equity Research

Skyworks Solutions Inc (SWKS)

HOLD. 12-month probability-weighted target $68 (-10% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

SWKSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.4%
Equity Research

Adobe Systems Incorporated (ADBE)

SELL. 12-month probability-weighted target $202 (-21% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

ADBEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -5.4%
Equity Research

Jabil Circuit Inc (JBL)

HOLD. 12-month probability-weighted target $340 (+9% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

JBLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -5.4%
Equity Research

Uipath Inc (PATH)

SELL. 12-month probability-weighted target $12 (-14% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

PATHEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -5.7%
Equity Research

Qualys Inc (QLYS)

SELL. 12-month probability-weighted target $154 (-9% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

QLYSEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -5.9%
Equity Research

Cognex Corporation (CGNX)

HOLD. 12-month probability-weighted target $63 (+2% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

CGNXEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.0%
Equity Research

Guidewire Software Inc (GWRE)

HOLD. 12-month probability-weighted target $150 (+0% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

GWREEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -6.0%
Equity Research

NVIDIA Corporation (NVDA)

SELL. 12-month probability-weighted target $199 (-12% vs spot). Revenue Growth explains 59% of Monte Carlo outcome variance.

NVDAEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -6.2%
Equity Research

Dynatrace Holdings LLC (DT)

SELL. 12-month probability-weighted target $45 (-10% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

DTEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -6.5%
Equity Research

Intuit Inc (INTU)

SELL. 12-month probability-weighted target $252 (-21% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

INTUEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -6.9%
Equity Research

Keysight Technologies Inc (KEYS)

HOLD. 12-month probability-weighted target $339 (+2% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

KEYSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.5%
Equity Research

Teledyne Technologies Incorporated (TDY)

HOLD. 12-month probability-weighted target $612 (+1% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

TDYEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.6%
Equity Research

Akamai Technologies Inc (AKAM)

HOLD. 12-month probability-weighted target $114 (+8% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

AKAMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -7.7%
Equity Research

Bill Com Holdings Inc (BILL)

HOLD. 12-month probability-weighted target $44 (-7% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

BILLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -8.3%
Equity Research

DocuSign Inc (DOCU)

SELL. 12-month probability-weighted target $54 (-17% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

DOCUEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -8.3%
Equity Research

Viavi Solutions Inc (VIAV)

HOLD. 12-month probability-weighted target $39 (+0% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

VIAVEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -9.0%
Equity Research

PTC Inc (PTC)

SELL. 12-month probability-weighted target $117 (-12% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

PTCEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -9.0%
Equity Research

Littelfuse Inc (LFUS)

HOLD. 12-month probability-weighted target $399 (-6% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

LFUSEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.1%
Equity Research

Seagate Technology PLC (STX)

HOLD. 12-month probability-weighted target $889 (+7% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

STXEquity ResearchMonte Carlo
30 August 2026Rating: HOLD · -11.2%
Equity Research

Advanced Energy Industries Inc (AEIS)

HOLD. 12-month probability-weighted target $280 (-3% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

AEISEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -11.8%
Equity Research

VeriSign Inc (VRSN)

SELL. 12-month probability-weighted target $256 (-9% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

VRSNEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -12.1%
Equity Research

TE Connectivity Ltd (TEL)

HOLD. 12-month probability-weighted target $188 (-8% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

TELEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.2%
Equity Research

Sanmina Corporation (SANM)

HOLD. 12-month probability-weighted target $196 (-4% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

SANMEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.2%
Equity Research

Oracle Corporation (ORCL)

HOLD. 12-month probability-weighted target $148 (-9% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

ORCLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.3%
Equity Research

Microsoft Corporation (MSFT)

SELL. 12-month probability-weighted target $420 (-15% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

MSFTEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -12.3%
Equity Research

MACOM Technology Solutions Holdings Inc (MTSI)

HOLD. 12-month probability-weighted target $269 (-2% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

MTSIEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.7%
Equity Research

Onto Innovation Inc (ONTO)

HOLD. 12-month probability-weighted target $278 (-1% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

ONTOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -12.8%
Equity Research

Trimble Inc (TRMB)

SELL. 12-month probability-weighted target $49 (-17% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

TRMBEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -13.0%
Equity Research

Datadog Inc (DDOG)

HOLD. 12-month probability-weighted target $240 (+14% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

DDOGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -13.3%
Equity Research

Twilio Inc (TWLO)

SELL. 12-month probability-weighted target $206 (-9% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

TWLOEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -15.0%
Equity Research

Tyler Technologies Inc (TYL)

SELL. 12-month probability-weighted target $279 (-20% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

TYLEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -15.2%
Equity Research

MKS Instruments Inc (MKSI)

SELL. 12-month probability-weighted target $232 (-13% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

MKSIEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -15.4%
Equity Research

Crane NXT Co (CXT)

HOLD. 12-month probability-weighted target $51 (+3% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

CXTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -15.8%
Equity Research

Kyndryl Holdings Inc (KD)

HOLD. 12-month probability-weighted target $14 (+6% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

KDEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -16.3%
Equity Research

Avnet Inc (AVT)

HOLD. 12-month probability-weighted target $84 (-9% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

AVTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -16.4%
Equity Research

Broadcom Inc (AVGO)

HOLD. 12-month probability-weighted target $360 (-2% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AVGOEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -17.3%
Equity Research

Synnex Corporation (SNX)

HOLD. 12-month probability-weighted target $246 (-5% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

SNXEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -17.4%
Equity Research

Dropbox Inc (DBX)

SELL. 12-month probability-weighted target $30 (-12% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

DBXEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -18.3%
Equity Research

Okta Inc (OKTA)

SELL. 12-month probability-weighted target $148 (-12% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

OKTAEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -18.5%
Equity Research

Fortinet Inc (FTNT)

HOLD. 12-month probability-weighted target $147 (-6% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

FTNTEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -21.0%
Equity Research

Manhattan Associates Inc (MANH)

SELL. 12-month probability-weighted target $167 (-20% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

MANHEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.2%
Equity Research

Motorola Solutions Inc (MSI)

SELL. 12-month probability-weighted target $401 (-13% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

MSIEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -21.6%
Equity Research

Monolithic Power Systems Inc (MPWR)

HOLD. 12-month probability-weighted target $1202 (-1% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

MPWREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -21.8%
Equity Research

CDW Corp (CDW)

SELL. 12-month probability-weighted target $131 (-9% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

CDWEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -22.2%
Equity Research

Nutanix Inc (NTNX)

SELL. 12-month probability-weighted target $54 (-20% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

NTNXEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -23.1%
Equity Research

Corning Incorporated (GLW)

HOLD. 12-month probability-weighted target $170 (+2% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

GLWEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -23.5%
Equity Research

Gen Digital Inc. (GEN)

SELL. 12-month probability-weighted target $24 (-21% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

GENEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -23.6%
Equity Research

ServiceNow Inc. (NOW)

SELL. 12-month probability-weighted target $98 (-27% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

NOWEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -23.9%
Equity Research

Accenture plc (ACN)

SELL. 12-month probability-weighted target $119 (-34% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

ACNEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -24.6%
Equity Research

Entegris Inc (ENTG)

HOLD. 12-month probability-weighted target $133 (-6% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

ENTGEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -25.5%
Equity Research

Lumentum Holdings Inc (LITE)

SELL. 12-month probability-weighted target $697 (-17% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

LITEEquity ResearchMonte Carlo
7 August 2026Rating: SELL · -25.8%
Equity Research

Cognizant Technology Solutions Corp Class A (CTSH)

SELL. 12-month probability-weighted target $39 (-36% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

CTSHEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -25.9%
Equity Research

Gartner Inc (IT)

SELL. 12-month probability-weighted target $129 (-25% vs spot). P/E Multiple explains 51% of Monte Carlo outcome variance.

ITEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -26.0%
Equity Research

Teradyne Inc (TER)

HOLD. 12-month probability-weighted target $358 (-4% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

TEREquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -26.1%
Equity Research

InterDigital Inc (IDCC)

SELL. 12-month probability-weighted target $261 (-23% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

IDCCEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -26.4%
Equity Research

Palantir Technologies (PLTR)

SELL. 12-month probability-weighted target $139 (-18% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

PLTREquity ResearchMonte Carlo
9 September 2026Rating: SELL · -27.1%
Equity Research

Marvell Technology Group Ltd (MRVL)

HOLD. 12-month probability-weighted target $211 (-6% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

MRVLEquity ResearchMonte Carlo
9 September 2026Rating: HOLD · -27.1%
Equity Research

NetApp Inc (NTAP)

SELL. 12-month probability-weighted target $149 (-21% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

NTAPEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -27.5%
Equity Research

Roper Technologies Inc (ROP)

SELL. 12-month probability-weighted target $329 (-17% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

ROPEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -27.5%
Equity Research

Apple Inc. (AAPL)

SELL. 12-month probability-weighted target $271 (-14% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AAPLEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -28.8%
Equity Research

HP Inc (HPQ)

SELL. 12-month probability-weighted target $24 (-24% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

HPQEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -28.8%
Equity Research

Belden Inc (BDC)

SELL. 12-month probability-weighted target $100 (-18% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

BDCEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -29.5%
Equity Research

Arista Networks (ANET)

SELL. 12-month probability-weighted target $157 (-19% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

ANETEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -31.8%
Equity Research

Workday Inc (WDAY)

SELL. 12-month probability-weighted target $119 (-36% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

WDAYEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -32.3%
Equity Research

Crowdstrike Holdings Inc (CRWD)

SELL. 12-month probability-weighted target $147 (-30% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CRWDEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -32.4%
Equity Research

Palo Alto Networks (PANW)

SELL. 12-month probability-weighted target $246 (-27% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PANWEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -33.2%
Equity Research

Lattice Semiconductor Corporation (LSCC)

SELL. 12-month probability-weighted target $99 (-15% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

LSCCEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -33.5%
Equity Research

Super Micro Computer Inc (SMCI)

SELL. 12-month probability-weighted target $30 (-25% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

SMCIEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -34.4%
Equity Research

Zebra Technologies Corporation (ZBRA)

SELL. 12-month probability-weighted target $252 (-29% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

ZBRAEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -35.7%
Equity Research

Dell Technologies Inc (DELL)

SELL. 12-month probability-weighted target $400 (-25% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

DELLEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -36.1%
Equity Research

Everpure, Inc. (P)

SELL. 12-month probability-weighted target $69 (-32% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

PEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -38.3%
Equity Research

Semtech Corporation (SMTC)

SELL. 12-month probability-weighted target $126 (-23% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

SMTCEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -38.7%
Equity Research

Salesforce.com Inc (CRM)

SELL. 12-month probability-weighted target $157 (-37% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

CRMEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -39.0%
Equity Research

Hewlett Packard Enterprise Co (HPE)

SELL. 12-month probability-weighted target $40 (-29% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

HPEEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -39.7%
Equity Research

Advanced Micro Devices Inc (AMD)

SELL. 12-month probability-weighted target $387 (-24% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

AMDEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -40.3%
Equity Research

Silicon Laboratories Inc (SLAB)

At the current quote Silicon Laboratories Inc is trading rich to the engine's triangulated fair value (-31%). The business — Silicon Laboratories Inc., a factory-less semiconductor company, provides mixed-signal…

SLABEquity ResearchMonte Carlo
30 July 2026Rating: N/A · -44.9%
Equity Research

Sitime Corporation (SITM)

SELL. 12-month probability-weighted target $409 (-32% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

SITMEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -45.4%
Equity Research

Intel Corporation (INTC)

SELL. 12-month probability-weighted target $47 (-55% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

INTCEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -57.2%
Equity Research

Novanta Inc (NOVT)

SELL. 12-month probability-weighted target $50 (-67% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

NOVTEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -61.8%
Equity Research

DigitalOcean Holdings Inc (DOCN)

SELL. 12-month probability-weighted target $62 (-51% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

DOCNEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -62.0%
Equity Research

Micron Technology (MU)

SELL. 12-month probability-weighted target $309 (-67% vs spot). Revenue Growth explains 45% of Monte Carlo outcome variance.

MUEquity ResearchMonte Carlo
30 August 2026Rating: SELL · -69.0%
Equity Research

Appfolio Inc (APPF)

SELL. 12-month probability-weighted target $77 (-63% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

APPFEquity ResearchMonte Carlo
9 September 2026Rating: SELL · -70.2%
MCH ADVISORY SERVICES · All research · Research, not personalised investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed